🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Cedar-IBSi Capital onboards institutional investors and family offices ahead of final close

EntrackrEntrackr · 2m ago
Cedar-IBSi Capital onboards institutional investors and family offices ahead of final close
Medial

Snippets Cedar-IBSi Capital onboards institutional investors and family offices ahead of final close FinTech specialist investor Cedar-IBSi Capital, focused on B2B financial infrastructure companies, has secured strong backing from leading institutional investors and over 20 family offices as it prepares to close its debut fund in the coming months. The fund has raised commitments worth Rs 100 crore with additional soft commitments worth Rs 10–15 crore and is confident of marking a Final Close in the coming months. Cedar-IBSi Capital’s institutional investors include Muthoot Finance, IIFL Capital, and an undisclosed Middle East royal family entity to be announced soon. Family office backers include Apar Industries, Varroc Engineering, the Taparia family, Dr. Reddy’s family office, among others. The fund has drawn strong interest from tier I institutions and prominent family offices due to its FinTech specialist expertise, the strategic advantages of co-investment opportunities, deep ecosystem access via the wider Cedar platform. The fund invests in Pre-A and A rounds, typically coming in as the first institutional investor. Initial investment cheques range between $500k–$1 million, with sufficient reserves kept for follow-on investments beyond simple pro-rata. Cedar-IBSi Capital aims to build a portfolio of 10–15 companies over the life of the fund. So far, it has invested in Cogniquest, an intelligent document processing company, and WonderLend Hubs, a cloud-based incentive compensation software provider. A third investment will be announced soon, with the fund actively evaluating multiple opportunities in the AI-for-Financial-Services space. Founded in 2024 by Sahil Anand, Cedar-IBSi Capital is an independent FinTech-focused investment fund built on the legacy of Cedar Consulting and IBS Intelligence’s global research and management consulting expertise. The fund invests in B2B FinTech companies developing software infrastructure for the global banking and financial services industry.

1

Related News

Filter Capital makes final close of Fund I Rs 800 Cr

EntrackrEntrackr · 1y ago
Filter Capital makes final close of Fund I Rs 800 Cr
Medial

Filter Capital, a technology-focused investment firm, has made the final close of its first fund at Rs 800 crore (approximately $96 million). The Mumbai-based fund received around 60% of the capital commitments from domestic limited partners (LPs), with the rest coming from international investors. According to an ET report, the LPs in the round included institutional investors and family offices such as HDFC Fund of Funds, Small Industries Development Bank of India, DSP family office, Amansa Capital founder Akash Prakash and Dream Sports cofounder Harsh Jain. Launched by Nithin Nayar and Sumit Sinha in 2018, Filter Capital will invest in Series B and C rounds in the range of $15-20 million. Filter Capital India Fund I has so far invested about Rs 225 crore from its corpus in four entities — enterprise loyalty software provider Capillary Technologies, bus mobility platform Chalo Mobility, e-commerce logistics services firm LoadShare Networks and healthcare enterprise software company THB. Recently, its portfolio firm Capillary Technologies extended its Series D round to $140 million, raising $95 million in secondary transactions to provide exits to existing investors and employees.

ChrysCapital closes $2.2 Bn Fund X

EntrackrEntrackr · 6d ago
ChrysCapital closes $2.2 Bn Fund X
Medial

ChrysCapital has closed Fund X at $2.2 billion, the largest private equity fund raised by an India-focused firm. Fund X is a 60% increase from Fund IX of $1.35 billion, closed in 2022. The firm plans to invest the capital in established companies across consumer, healthcare, financial services, enterprise technology, and industrial sectors. ChrysCapital has now raised around $8.5 billion across ten private equity funds, a continuation vehicle, and a public markets fund since 1999. It has deployed over $5.5 billion across 110 portfolio companies and realised $7.8 billion across 80 exits with a reported 3.0x ROI. Its past investments include Intas Pharmaceuticals, Mankind Pharma, GeBBS Healthcare, Infogain, NSE, and Awfis. Fund X added over 30 new global investors, including pension funds, insurers, asset managers, and family offices from Japan, the Middle East, Southeast Asia, Europe, and the US. For the first time, ChrysCapital also raised capital from Indian institutional investors and large family offices. The fund reached its final close within six months of its first close. The firm plans to deploy Fund X over the next 3–4 years and has several transactions in progress. The strategy continues to focus on majority and minority investments in businesses with strong governance, clear growth levers, and defined exit visibility. ChrysCapital competes with PE firms active in India such as TPG, Bain Capital, KKR, Blackstone, Carlyle, Warburg Pincus, and Multiples.

Download the medial app to read full posts, comements and news.